Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | GSK PLC | 62 |
| 2 | Eisai Co Ltd | 21 |
| 3 | Cornell University | 14 |
| 4 | Johnson and Johnson | 14 |
| 5 | Nisshin Seifun Group Inc | 13 |
| 6 | Novo Nordisk Fonden | 13 |
| 7 | Purdue University System | 12 |
| 8 | AstraZeneca PLC | 11 |
| 9 | Toyota Motor Corp | 11 |
| 10 | University of Iowa | 11 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 230 |
| 2 | C07K | Peptides | 177 |
| 3 | A61P | Therapeutic activity (drug indications) | 175 |
| 4 | C12N | Microorganisms, enzymes | 165 |
| 5 | Y02A | Climate change adaptation | 91 |
| 6 | C12P | Fermentation, enzyme processes | 87 |
| 7 | C12Y | Enzyme nomenclature (EC numbers) | 60 |
| 8 | C12Q | Measuring/testing involving enzymes | 55 |
| 9 | C12R | 34 | |
| 10 | G01N | Investigating / analysing materials | 32 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee |
|---|---|---|
| Use of undecaprenol kinase inhibitors to inhibit cell wall biosynthesis | 2001 | |
| USE OF INHIBITORS OF UNDECAPRENOL KINASE TO INHIBIT CELL WALL BIOSYNTHESIS | 2000 | State University System of Florida |
| USE OF INHIBITORS OF UNDECAPRENOL KINASE TO INHIBIT CELL WALL BIOSYNTHESIS | 1998 | State University System of Florida |
| Use of inhibitors of undecaprenol kinase to inhibit cell wall biosynthesis | 1998 | State University System of Florida |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Dominique Mengin‐Lecreulx | Institut de Biochimie et Biophysique Moléculaire et Cellulaire | 2 |
| 2 | Tadeusz Chojnacki | Polish Academy of Sciences | 2 |
| 3 | Mary Osborn | UConn Health | 2 |
| 4 | Frederic A. Troy | University of California, Davis | 2 |
| 5 | Francesca M. Alexander | University of Ulster | 1 |
| 6 | Christine Mulford | UConn Health | 1 |
| 7 | Luke Masson | 1 | |
| 8 | Chung‐Yi Chen | Fooyin University | 1 |
| 9 | Adrien Ducret | Lyon 1 Université | 1 |
| 10 | Wen‐Li Lo | Fooyin University | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Close Is Not Enough | 2000 | 303 | Lipid Membrane Structure and Behavior |
| An intermediate step in translocation of lipopolysaccharide to the outer membrane of Salmonella typhimurium. | 1983 | 102 | Lipid Membrane Structure and Behavior |
| Quantitative high-performance liquid chromatography analysis of the pool levels of undecaprenyl phosphate and its derivatives in bacterial membranes | 2008 | 94 | Bacterial Genetics and Biotechnology |
| 2H NMR investigation of the organization and dynamics of polyisoprenols in membranes. | 1985 | 65 | Lipid Membrane Structure and Behavior |
| The Stress-Responsive dgk Gene from Streptococcus mutans Encodes a Putative Undecaprenol Kinase Activity | 2003 | 50 | Genomics and Phylogenetic Studies |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of undecaprenol?
Which organizations hold the most patents involving undecaprenol?
What is the primary application focus for undecaprenol-related patents?
What research topics have been published about undecaprenol?
Who are prominent researchers studying undecaprenol?